With increasing shortage of fresh water globally, more countries are consuming desalinated seawater (DSW). In Israel >50% of drinking water is now derived from DSW. Desalination removes magnesium, and hypomagnesaemia has been associated with increased cardiac morbidity and mortality. Presently the impact of consuming DSW on body magnesium status has not been established. We quantified changes in serum magnesium in a large population based study (n ¼ 66,764), before and after desalination in regions consuming DSW and in regions where DSW has not been used. In the communities that switched to DSW in 2013, the mean serum magnesium was 2.065 ± 0.19 mg/dl before desalination and fell to 2.057 ± 0.19 mg/dl thereafter (p < 0.0001). In these communities 1.62% of subjects exhibited serum magnesium concentrations 1.6 mg/dl between 2010 and 2013. This proportion increased by 24% between
INTRODUCTION
In many regions worldwide, fresh water needs exceed the available supply, leading to the rapid development of technologies for desalinating sea and brackish water. Presently, an estimated 300 million people worldwide consume desalinated seawater (DSW) (Desalination Association ).
Israel is among leading countries in the production of DSW, accounting now for over 50% of the country's tap water consumption. Hence any potential health effects of DSW may have serious impact on large populations (Spungen et al. ).
Fresh water from the Israeli National Water Carrier (NWC) contains 20-25 mg magnesium per litre. In contrast, DSW contains virtually no magnesium due to its removal during the desalination process (Yermiyahu et al. ) . The World Health Organization (WHO) report on drinking water, stresses that where a supply is moving to low-mineral desalinated water, one should consider replenishing with magnesium salt (WHO ). However, to date no analysis exists where the impact of such changes was measured directly on the body burden of magnesium.
Because regular ('hard') water accounts for 7.5-17% of the daily requirements of magnesium (Maraveri et al. ) , the rest coming from nutritional sources, it is critical to investigate whether this potential shortage is clinically relevant. Because in Israel the fraction of DSW in drinking water is the highest among all developed countries (Yermiyahu et al. ) , this is a unique experimental opportunity to assess whether the massive introduction of seawater desalination has been associated with a clinically relevant decrease in the body burden of magnesium, potentially putting people at increased risk of cardiovascular morbidity and mortality.
The aim of the present study was to quantify potential changes in serum magnesium in a large population-based study, comparing levels before and after desalination in regions that used or did not use DSW.
METHODS
The study was approved by the Assuta hospital IRB. Using anonymous data unlinked to patients, consent was waivered. The present retrospective cohort study was carried out using data from the computerized files of Maccabi The study periods compared therefore the years 2010-2013 vs. 2014-2016.
The information published officially regarding distribution of DSW was cross checked by measuring magnesium in 53 samples of tap water from areas of both DSW and non-DSW use. The mean magnesium levels in the DSW communities was 5.4 mg/l (range 0-9.42), compared to 25.1 mg/l (11-37.5) in tap water from naturally occurring 'hard' water.
For the years studied, we extracted from the MHS database all serum magnesium measurements performed on MHS members residing in the selected communities.
When more than one measurement was available, only the first one was included. All measurements were performed in a single MHS central laboratory.
Using the unpaired Student's t test we compared mean serum magnesium concentrations for the period of 2010-2013 to 2014-2016 in communities consuming mostly DSW, as well as for the communities consuming natural water. In parallel, using the Chi square test, we compared for the same periods the proportions of magnesium concentrations equal or below the lower normal range of 1.6 mg/dl.
RESULTS
A total of 66,764 subjects had serum magnesium concentrations available in communities that used or did not use DSW.
The normal range of serum magnesium concentrations is 1.7-2.4 mg/dl (0.7-1 mmol/l; 1.5-2 mEq/l) (Williamson et al. ) . In the communities that switched to DSW in 2013, the mean serum magnesium was 2.065 ± 0.19 mg/dl before desalination. Following desalination, mean levels decreased to 2.057 ± 0.19 (p < 0.0001). In these communities 1.62% of subjects exhibited serum concentrations 1.6 mg/dl during 2010-2013. Their proportion increased by 18.5% in 2014-2016 to 1.91% (p ¼ 0.0057) (Table 1) .
Further sub-analysis compared the proportion of low magnesium concentrations 1.6 mg/dl in 2010-2013 to 
DISCUSSION
Although the WHO recommends careful follow up of potential changes in magnesium status after introduction of DSW, there is virtually no published data to quantify the potential health risks in humans.
In a recent study from Spain, the fraction of daily magnesium intake provided by water consumption in adults was estimated at 7.5-17% assuming magnesium tap water However, this study did not follow magnesium levels in most patients. Importantly, the increase in the proportion of low magnesium levels was gradual, corresponding to more and more DSW replacing natural fresh water. Critically no similar changes were shown in communities where DSW was not introduced. It is conceivable that individuals who already have a tendency toward lower magnesium levels, such as those using diuretics ( 
